相关实验视频

Updated: Jul 4, 2025

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

诱导癌细胞死亡的机制由triptolide:一个全面的概述

Ke Feng¹, Xiaojiang Li¹, Yuzhuo Bai²

¹Department of General Surgery, Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun, 130000, China.

|January 31, 2024

概括

来自Tripterygium Wilfordii的天然化合物Triptolide通过诱导癌细胞死亡和增强化疗,在癌症治疗中显示出有前途. 关于三类组合疗法和向输送系统的进一步研究正在进行中.

科学领域:

自然产品化学化学
癌症生物学癌症生物学
药理学药理学是指药理学的学科.

背景情况:

癌症患病率上升需要新的治疗药物,其副作用比传统化疗药物少.
来自Tripterygium Wilfordii的Triptolide是一种具有显著抗癌潜力的关键天然化合物.
了解三胺的分子机制对于开发有效的癌症治疗至关重要.

研究的目的:

探索三类对各种瘤的生物机制和治疗潜力.
为了确定关键的分子标和ptolide 在癌细胞中调节的途径.
评估三胺与现有化疗药物结合的疗效,并评估新的输送策略.

主要方法:

临床前研究分析了triptolide对癌细胞亡的影响.
识别分子标,包括热冲击蛋白70 (HSP70),循环素依赖激酶 (CDK) 和其他如MKP1,基因组甲基转移酶和RNA聚合酶.
探索三类对细胞通路 (如自和AKT信号传递) 的影响,以及其与ADAM10,PC-2,DCTP1,Prx-I,TAB1,DNA-PKcs和XPB等蛋白质的相互作用.
评估triptolide与化疗药物的协同效应,并研究向的输送系统 (联结,纳米载体).

主要成果:

托利通过抑制HSP70和CDKs和P21的上调调节来促进细胞亡,从而诱导癌细胞死亡.
确定了多个分子标和受triptolide影响的信号通路,包括自,AKT和各种蛋白质相互作用.
证明了triptolide提高常规化疗药物的有效性的能力.
展示了针对性策略的潜力,如带结合和纳米载体,以减轻三类的毒性.

结论:

特里普托利德通过多种分子机制表现出显著的抗癌特性,包括亡诱导和关键细胞通路的调制.
特里普托利德作为辅助疗法具有前景,增强现有癌症治疗的疗效.
有针对性的输送系统和涉及三胺的组合疗法对于优化其治疗指数和未来临床应用至关重要.

关键词:

这是一种抗瘤药物.细胞灭亡 (apoptosis) 是一种死亡的过程.癌症机制癌症机制目标化目标化目标化目标化三托利化物是什么

更多相关视频

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

相关概念视频

Overview of Cell Death

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...

The Intrinsic Apoptotic Pathway

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

Drugs that Destabilize Microtubules

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...